Cancer Cell Metabolism Database ~~ Bioinformatics and Systems Medicine Laboratory ~~

Cancer Cell Metabolism Gene Database

Cancer Cell Metabolism Gene DB

Home

	Gene Summary
	Phenotypic Information (metabolism pathway, cancer, disease, phenome)
	Mutations : SVs, CNVs, SNVs
	Gene expression: GE, Protein, DEGE, CNV vs GE
	Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG
	Pharmacological Information: Drug-Gene Network
	Cross referenced IDs

Gene Summary for POLR2G

Basic gene info.	Gene symbol	POLR2G
	Gene name	polymerase (RNA) II (DNA directed) polypeptide G
	Synonyms	RPB19\|RPB7\|hRPB19\|hsRPB7
	Cytomap	UCSC genome browser: 11q13.1
	Genomic location	chr11 :62529010-62534187
	Type of gene	protein-coding
	RefGenes	NM_002696.2,
	Ensembl id	ENSG00000168002
	Description	DNA directed RNA polymerase II 19 kda polypeptideDNA-directed RNA polymerase II 19 kDa polypeptideDNA-directed RNA polymerase II subunit GDNA-directed RNA polymerase II subunit RPB7RNA polymerase II 19 kDa subunitRNA polymerase II seventh subunitRNA
	Modification date	20141207
dbXrefs	MIM : 602013
	HGNC : HGNC
	Ensembl : ENSG00000168002
	HPRD : 15995
	Vega : OTTHUMG00000167609
Protein	UniProt: P62487 go to UniProt's Cross Reference DB Table
Expression	CleanEX: HS_POLR2G
	BioGPS: 5436
	Gene Expression Atlas: ENSG00000168002
	The Human Protein Atlas: ENSG00000168002
Pathway	NCI Pathway Interaction Database: POLR2G
	KEGG: POLR2G
	REACTOME: POLR2G
	ConsensusPathDB
	Pathway Commons: POLR2G
Metabolism	MetaCyc: POLR2G
	HUMANCyc: POLR2G
Regulation	Ensembl's Regulation: ENSG00000168002
	miRBase: chr11 :62,529,010-62,534,187
	TargetScan: NM_002696
	cisRED: ENSG00000168002
Context	iHOP: POLR2G
	cancer metabolism search in PubMed: POLR2G
	UCL Cancer Institute: POLR2G
Assigned class in ccmGDB	B - This gene belongs to cancer gene.

Top

Phenotypic Information for POLR2G(metabolism pathway, cancer, disease, phenome)

Cancer Description
Cancer	CGAP: POLR2G
	Familial Cancer Database: POLR2G

* This gene is included in those cancer gene databases.

						.
Oncogene ¹	Tumor Suppressor gene ²	Cancer Gene Census ³	CancerGenes ⁴	Network of Cancer Gene ⁵	Significant driver gene in	Therapeutic Vulnerabilities in Cancer¹

cf) number; DB name
1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long,
2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/,
3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html,
4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long,
5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php,
1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/

Metabolic Pathway Description
KEGG_PURINE_METABOLISM KEGG_PYRIMIDINE_METABOLISM

Others
OMIM	602013; gene.
Orphanet
Disease	KEGG Disease: POLR2G
	MedGen: POLR2G (Human Medical Genetics with Condition)
	ClinVar: POLR2G
Phenotype	MGI: POLR2G (International Mouse Phenotyping Consortium)
Phenotype	PhenomicDB: POLR2G

Mutations for POLR2G

* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site.

Structural Variants in COSMIC : go to COSMIC mutation histogram

There's no structural variation information in COSMIC data for this gene.

Related fusion transcripts : go to Chitars2.0

* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows POLR2G related fusion information.

Head Gene

Tail Gene

Accession

Gene_a

qStart_a

qEnd_a

Chromosome_a

tStart_a

tEnd_a

Gene_a

qStart_a

qEnd_a

Chromosome_a

tStart_a

tEnd_a

CB048938

SMAP1

71428519

71428545

POLR2G

454

62532833

62534182

Other DBs for Structural Variants

Structural Variants in Ensembl: go to Ensembl Structural variation

Structural Variants in dbVar: go to dbVar

Top

Copy Number Variations in COSMIC : go to COSMIC mutation CNV/Expr

There's no copy number variation information in COSMIC data for this gene.

Top

SNV Counts per Each Loci in COSMIC data : go to COSMIC point mutation

: Non-synonymous mutation, : Synonymous mutation, Circle size denotes number of samples.
Maximum mutation count=2

Top

Somatic Mutation Counts per Tissue in COSMIC data

Stat. for Non-Synonymous SNVs (# total SNVs=9)	Stat. for Synonymous SNVs (# total SNVs=2)

Stat. for Deletions (# total SNVs=0)	Stat. for Insertions (# total SNVs=0)
There's no deleted snv.	There's no inserted snv.

Top

Top 10 SNVs Having the Most Samples in COSMIC data

* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID.

GRCh37 position	Mutation(aa)	Unique sampleID count
chr11:62530364-62530364	p.T50P	1
chr11:62530370-62530370	p.D52N	1
chr11:62532667-62532667	p.T99I	1
chr11:62532690-62532690	p.F107I	1
chr11:62532822-62532822	p.S115L	1
chr11:62533155-62533155	p.R144C	1
chr11:62533156-62533156	p.R144H	1
chr11:62533177-62533177	p.R151P	1
chr11:62529276-62529276	p.E8*	1
chr11:62533187-62533187	p.K154K	1

Top

SNV Counts per Each Loci in TCGA data

: non-synonymous mutation, : synonymous mutation, Circle size denotes number of samples.
maximum mutation count=2

Point Mutation/ Tissue ID	1	2	3	4	5	6	7	8	9	10	11	12	13	14	15	16	17	18	19	20
# sample		1					1					2					1	1
# mutation		1					1					3					1	1
nonsynonymous SNV							1					2						1
synonymous SNV		1										1					1

cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma])

Top

Top 10 SNVs Having the Most Samples in TCGA data

* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID.

Genomic Position	Mutation(aa)	Unique sampleID count
chr11:62532822	p.S115L	2
chr11:62532699	p.S112S	1
chr11:62532814	p.R144H	1
chr11:62533156	p.K154K	1
chr11:62533187	p.D52N	1
chr11:62530370	p.G55C	1
chr11:62530379	p.R110R	1

Other DBs for Point Mutations

Point Mutation Table of Ensembl: go to Ensembl variation table

Mutation of cBioPortal: go to cBioPortal's Cross-cancer alteration summary

Copy Number for POLR2G in TCGA

* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene.

cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma]

Top

Gene Expression for POLR2G

Gene Expression in Cancer Cell-lines (CCLE)

* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data.

Differential Gene Expression in Primary Tumors (TCGA)

* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis.
(t test, adjusted p<0.05 (using Benjamini-Hochberg FDR))

Top

CNV vs Gene Expression Plot

* This plots show the correlation between CNV and gene expression.

: Open all plots for all cancer types

Top

Gene-Gene Network Information

Co-Expressed gene's network Plot

* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown.
Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene

: Open all plots for all cancer types


B3GAT3,BANF1,BSCL2,TMEM258,LBHD1___C11orf98,UQCC3,CFL1, COX8A,FIBP,OTUB1,POLR2G,PPP1R14B,SDHAF2,SSSCA1, STX5,TIMM10,TMEM179B,TMEM223,TRMT112,TTC9C,WDR74	APOA1BP,BUD31,C17orf49,CLTA,JTB,KDELR1,LSM2, MRPL17,MRPS21,NSMCE1,PFDN5,PHF5A,POLR2G,PPIA, SEC61B,SNRPF,TMEM179B,TMEM223,UBE2I,UFC1,YIPF3

ARL2,ATP5L,BANF1,TMEM258,C11orf31,LAMTOR1,C11orf73, COA4,EMG1,FAU,MRPL11,MRPL48,MRPL49,MRPS23, POLR2G,PPP1CA,SDHAF2,TIMM8B,TMEM126A,TMEM223,TRMT112	ADSL,ELP6,TMEM261,COPS3,DAP3,GEMIN6,HAUS1, HAX1,LSM2,MRPL51,NAA20,NDUFA4,NHP2,POLE3, POLR2G,PSMD10,SIVA1,SNRPC,SNRPD2,TOMM6,ZNF511

Co-Expressed gene's Protein-protein interaction Network Plot

: Open all plots for all cancer types

Top

Interacting Genes (from Pathway Commons)

: Open all interacting genes' information including KEGG pathway for all interacting genes from DAVID

Top

Pharmacological Information for POLR2G

There's no related Drug.

Top

Cross referenced IDs for POLR2G

* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section

: Open all cross reference information